Chartomatsidou, E., Ntoufa, S., Kotta, K., Rovida, A., Akritidou, M. A., Belloni, D., . . . Stamatopoulos, K. (2019). Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia. Blood Adv.
Styl cytowania ChicagoChartomatsidou, Elisavet, et al. "Inhibition of EZH2 and Immune Signaling Exerts Synergistic Antitumor Effects in Chronic Lymphocytic Leukemia." Blood Adv 2019.
Styl cytowania MLAChartomatsidou, Elisavet, et al. "Inhibition of EZH2 and Immune Signaling Exerts Synergistic Antitumor Effects in Chronic Lymphocytic Leukemia." Blood Adv 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..